2022 American Transplant Congress
Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for T2 Hepatocellular Carcinoma and May Allow for Decreased Mortality
*Purpose: Prior studies have suggested that induction therapy leads to worse outcomes after liver transplantation (LT) for hepatocellular carcinoma (HCC). This study evaluated the impact…2022 American Transplant Congress
Post-Allocation Policy and Changes in Gender Disparities in Access to Simultaneous Liver and Kidney Transplantation
*Purpose: Gender-based differences in receiving simultaneous liver-kidney transplant (SLKT) is not well-understood. We recently found that women are disadvantaged in access to SLKT, especially women…2022 American Transplant Congress
Miami Protocol for Liver Deceased Donors After Circulatory Death: Increased 1-year Overall Survival for Selected Patients
University of Miami, Jackson Memorial Hospital, Miami Transplant Institute, Miami, FL
*Purpose: The use of deceased donors after circulatory death (DCD) for liver transplantation (LT) is still underutilized. It provides an acceptable solution to increase the…2022 American Transplant Congress
Outcome of Solid Organ Transplantation in Candidates with Intellectual Disability: A Systematic Review
Erasmus MC, Rotterdam, Netherlands
*Purpose: The allocation of organs comes with an ethical discussion in patients with intellectual disability. Historically, intellectual disability was considered a relative contra-indication for organ…2022 American Transplant Congress
Transplant Combined with Neoadjuvant Therapy Improves Survival for Patients with Liver-Limited, Locally Advanced Intrahepatic Cholangiocarcinoma: A SEER Database Analysis
*Purpose: Preliminary single-center data suggest multimodal therapy may improve outcomes for patients with intrahepatic cholangiocarcinoma (iCCA) undergoing liver transplant (LT), particularly in the setting of…2022 American Transplant Congress
Simultaneous Liver and Kidney Transplantation and Gender Disparities in Transplant Access and Outcomes
*Purpose: The frequency of simultaneous liver-kidney transplantation (SLKT) has been rising since the implementation of the Model for End-stage Liver Disease (MELD)-liver allocation system in…2022 American Transplant Congress
Liver Transplantation is Beneficial Regardless of Cirrhosis Stage or Acute-on-Chronic Liver Failure Grade: A Single-Center Experience
*Purpose: Liver transplantation for the most critically ill remains controversial; however, it is currently the only curative treatment option. The aim of this study was…2022 American Transplant Congress
Multidimensional Prognostication Tool for Kidney Transplant Patient Survival: The Mortality Mbox
*Purpose: Predicting kidney transplant patient mortality has been hampered by registry-based studies and low level phenotyped cohorts without specific design towards mortality prediction. This represents…2022 American Transplant Congress
Clinical Outcomes of Solid Organ Transplant (SOT) Patients with Epstein-Barr Virus-Driven (EBV+) Post-Transplant Lymphoproliferative Disease (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study
*Purpose: EBV+ PTLD patients (pts) following SOT who fail rituximab + chemotherapy (CT) have poor outcomes with limited treatment options. Published data on clinical outcomes…2022 American Transplant Congress
Fontan versus Non-Fontan Combined Heart-Liver Transplantation: Proceed but Cautiously
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Combined heart-liver transplantation (CHLT) is increasing, corresponding with a growing prevalence of Fontan-associated end-organ damage. We aimed to describe our contemporary institutional experience with…
- 1
- 2
- 3
- …
- 66
- Next Page »